51.82
price down icon0.12%   -0.06
after-market Handel nachbörslich: 51.40 -0.42 -0.81%
loading

Finanzdaten der Akero Therapeutics Inc-Aktie (AKRO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
5.14%
50.65
53.39 38.63 27.98 21.79
Interest Income/Expense
10.48%
0.991
0.897 0.888 0.857 0.457
Operating Income/Loss
3.10%
-59.95
-61.87 -46.62 -35.63 -28.75
Income/Loss From Continuing Operations Before Tax
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Income/Loss From Continuing Operations After Tax
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Net Income/Loss
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,488%
59.31
1.0614 55.61 51.87 46.94
Diluted Average Shares
5,488%
59.31
1.0614 55.61 51.87 46.94
Basic Earnings Per Share
11.76%
-0.90
-1.02 -0.71 -0.60 -0.55
Diluted Earnings Per Share
11.76%
-0.90
-1.02 -0.71 -0.60 -0.55
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):